given level of angiotensin II may be high, and both have normal exchangeable sodium. The puzzle remains why the correlation between aldosterone and angiotensin II should be so weak, since here the adrenal is if anything more than normally sensitive to angiotensin II stimulation.
The question of the nature of essential hypertension was further examined by the last speaker of the day, Dr J C'Melby (Boston) . In contrast to the Glasgow group, Melby believes that low renin essential hypertension is a separate phenomenon, possibly caused or characterized by a number of features. These include a sodium-dependent blood volume expansion (populations with high sodium diets have high incidence of hypertension) reduced GFR (primary renal sodium retention), and mineralocorticoid (or hypertensinogenic) steroid excess. Other forms of low renin essential hypertension may arise from altered juxtaglomerular function, pressure natriuresis reset in the kidney, decreased fj-adrenergic activity, or through decreased vascular capacitance. The involvement of the adrenal cortex in a number of cases seems clear: hypertension can be reduced by the aldosterone antagonist spironolactone, or by inhibitors of steroidogenesis such as aminoglutethimide or trilostane. The question is: what is stimulating which steroid? One possibility mentioned by Coghlan is that further as yet uncharacterized adrenocortical stimulants may exist. Additionally, as yet uncharacterized steroids may be involved. Some relatively unfamiliar steroids have been studied by Dr Melby and his group: these include l8-hydroxydeoxycorticosterone and 16a,18-
Social and biological effects on perinatal mortality!
One of the more exciting growth areas today is preventive medicine. It is in the beginning of life that the prevention of death, disease and disability fancy and childhood, due to improvements in sanitation and housing as much as to medical care. Deaths in the perinatal period have proved more resistant because they are less directly influenced by environmental measures, and thus present a greater challenge to the medical profession. These deaths have now assumed a substantial importance in developed countries, both because they are dihydroxydeoxycorticosterone. Neither seems to fit the bill but Melby ;s careful to point out that hypertensinogenic activity and classical mineralocorticoid activity do not necessarily always go hand in hand. It seems most likely that the entire range of biologically active steroids produced by the adrenal cortex has not been recognized even now. The breadth ofthis symposium was thus remarkable: and the meeting highlighted, at least for this reviewer, the point that despite 25 years activity, certain fundamental problems about aldosterone remain. These include: how is aldosterone biosynthesized? What is the primary mode of its action? Do further, uncharacterized, factors exist which control aldosterone secretion? What is the relationship of aldosterone and the adrenal cortex to hypertension? No clear answers emerge, yet in posing these questions to perhaps a larger audience than normally listen to aldosterone papers, the symposium (whose proceedings will appear in a special edition of the Journal of Endocrinology) served a valuable function. GAVIN representing an increasing proportion of all mortality, and because it has been shown that their rate acts as a sensitive indicator of social circumstances and medical care. Considerable efforts are therefore going into their reduction, both at the clinical and the population level. One of the time-honoured epidemiological tools used to bring about this reduction has been the use of international comparisons. These, like intranational comparisons, can be used in many different ways. One way, popular with politicians and administrators, is to publicize them to generate a competitive spirit and stimulate more active preventive measures in those areas with a poor performance. Another is to use them as a guide for differential resource allocations. However, such uses are only legitimate if it can be shown that the differences demonstrated are real, and not explained by definitions, or certification or coding practices. Once real differences are demonstrated they may act as useful pointers to aetiological factors, or to successful preventive measures.
The grouping of late fetal (28 weeks gestation or more) with first week deaths, 'perinatal deaths', minimizes one major problem of comparative studies, namely differences in the definition of 'signs of life'. Moreover, a large proportion of the causes of late fetal deaths (stillbirths) and of first week (early neonatal) deaths are common to both. Comparability problems still exist, for some countries have different lower gestational limits to distinguish between stillbirths and earlier fetal deaths. Several countries also have birthweight or fetal length limits, below which a fetus is not counted, being considered nonviable. Even the definition of the first week of life presents problems, some countries counting the first day from the hour of birth, some counting only calendar days. In the first 24 hours of life mortality rates fall sharply within minutes of birth, then with each hour oflife, so that even minor variations in the definition of age can make some differences to comparability of data.
Moreover, it is now well known that perinatal mortality rates vary substantially with social and biological factors, including maternal age and parity, socioeconomic conditions, sex, and above all the maturity of the baby, usually measured in terms of its birthweight. Variations in the distribution of such factors certainly explain some of the wide range of perinatal mortality rates found even within the developed countries. Without standardization of definitions and grouping of variables, it has been impossible to assess the magnitude of any real differences in perinatal mortality risk between comparable groups of mothers in different countries, or indeed whether perinatal mortality consistently behaves in the same way in relation to these groups.
It was to answer such questions, and to stimulate countries to look at their own data in more detail, that the World Health Organizations set up a Comparative Study of Social and Biological Effects on Perinatal Mortality, with eight participating countries. A preliminary account of this study was given to the Section of Epidemiology and Community Medicine on 9 March 1978 by its Scientific Director, Professor Neville Butler, and two collaborators, Dr Peter Lambert and Miss Jackie Hellier.
The participating countries comprised England and Wales, Austria, Cuba, Hungary, Japan, New Zealand, Sweden and the USA. For each country except New Zealand the study was of births occurring in 1973. New Zealand, because of 'the small number of births, provided information on 1972 and 1973 perinatal deaths. Japan and the USA provided samples only, Japan of births in certain months only, the USA of certain States only. The study was based on data produced by the usual registration and notification practices of the countries concerned, but each country except England and Wales agreed on 18 items which it would record, code, and transmit to WHO in a standard format for central computer processing. Because of the confidential requirements in England and Wales the data collected in this country were processed locally and the required tabulations were provided. Notable also is the regrettable fact that England and Wales were the only countries not able to provide birthweight data, for this item is not among those collected at live birth registration. Most of the countries were able to provide an agreed coding of occupation or length of education received, usually for the fathers of the births.
The basis of the analyses was the relationship of perinatal mortality rates to the standardized social and biological factors within and between countries. Dr Lambert stressed the universality of such patterns of perinatal mortality in the different countries. Above all else, perinatal mortality rates (PMR) were influenced by the distribution of birthweight within the countries. The rank order of crude PMRs by country was largely that of the proportion of low birth weight babies, and although Sweden and Hungary were at the top and bottom ends ofthe study range ofPMRs, standardization for birthweight brought the USA into the first position and Hungary into the third.
The social class gradient in mortality in England and Wales, particularly at the youngest ages, is one which exercises us a great deal; however, a regrouping of parental social class in the agreed standard format for the study showed that the gradient for PMR differed little from that of Austria or New Zealand. Also important was the demonstration that although urban-rural differences vaned (three countries having higher rates in urban than rural areas, three showing the opposite, and two no difference), standardization of birthweight (where available) converted all the countries in the study to a low-urban/high-rural gradient, hinting that easy access to good medical care may be important everywhere, over and above demographic and other differences. This suggestion has recently been validated in a Norwegian study (Bakketeig et al. 1978) .
. To produce the information needed for the WHO study, data on early neonatal deaths occuring in England and Wales in 1973 were linked to their respective birth records, so that information on social class of the family and maternal age and parity, not normally available on neonatal deaths, could be obtained. This made the information compatible with an earlier study by Heady & Heasman (1959) and made it possible for Miss Hellier to assess how much of the fall in PMR in England and Wales between 1950 and 1973 was due to favourable changes in the distributions of maternal age, parity and social class between these years. She showed that slightly over one quarter of the decrease could be explained by such changes, representing some 2000 additional survivors a
year, but pointed out that the remainder of the fall must be due to better maternal health and improved medical care. Miss Hellier went on to do a similar comparison of the PMRs found in the different Hospital Regions in England and Wales in 1973, after allowing for the different distribution of social class and maternal parity and age groups found in each. She showed that such differences will explain differences in PMRs in 8 out of the 15 Regions, but would not explain the remaining differences, or the extremes observed. Again, these findings suggest that differences in medical care, or its availability, may be the explanation.
Professor Butler gave the meeting an account of the differences in given causes of death, and the standardization of their coding, which is so important in international comparisons. To minimize coding differences and their effects a standard system of multiple cause coding was adopted. Each country contributed a set of about 200 coded death certificates which were checked centrally. Any coding anomalies were reported back to the country concerned, usually in the course of site visits at which the coding rules were further explained.
Major differences in cause of death certification emerged from this study, largely related to the form of certificate used. Those countries which used a form of 'perinatal' certificate, common to both stillbirths and neonatal deaths, also provided reminders in terms of check lists, or by the format of the certificate, that 'maternal' causes could be assigned as causes of perinatal deaths. In those countries such causes appeared far more commonly than where such reminders were not avail-able, as when the standard International Death Certificate is used for neonatal deaths.
Attempts were made to 'adjust' for such differences, and these showed that as for crude PMRs the four major groups of cause (maternal, obstetric, fetal and fetal/maternal) showed a definite and markedly uniform pattern in the different countries with the biological variables tested. Examples were the high risk from a maternal cause (especially from toxaemia) in first births, falling in the second and rising subsequently, and the steady increase with parity in PMR from placental haemorrhage and haemolytic disease.
The full results of the studies reported here, with other related analyses of multiple births, outcome of teenage pregnancies, and the use of multiplecause death coding will be available from WHO in the near future. Such studies are of great value in the continuing efforts made by all countries to reduce perinatal mortality. The most important question raised is undoubtedly the reason for the observed international differences in birthweight distribution, which underlie such a substantial proportion of differences in mortality. Japan is the only country in which a difference in this distribution has been reported in recent years, with a fall in the proportion of low birthweight babies. The reasons for this fall remain obscure, although it seems likely to be related to the rapid rise in the standard of living seen in Japan since the last war. This problem must surely still remain one of the most important research areas, and should itself become the subject of an international collaborative study, looking at the effect (amongst others) of parental height, health and nutrition.
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